001     185976
005     20210129214756.0
024 7 _ |a 10.1007/s00232-014-9700-x
|2 doi
024 7 _ |a pmid:25192977
|2 pmid
024 7 _ |a 0022-2631
|2 ISSN
024 7 _ |a 1432-1424
|2 ISSN
024 7 _ |a WOS:000343835500019
|2 WOS
024 7 _ |a altmetric:17089466
|2 altmetric
037 _ _ |a FZJ-2015-00085
041 _ _ |a eng
082 _ _ |a 570
100 1 _ |a Polovinkin, V.
|0 P:(DE-HGF)0
|b 0
245 _ _ |a High-resolution structure of a membrane protein transferred from amphipol to a lipidic mesophase.
260 _ _ |a New York, NY
|c 2014
|b Springer
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1420632452_23891
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
520 _ _ |a Amphipols (APols) have become important tools for the stabilization, folding, and in vitro structural and functional studies of membrane proteins (MPs). Direct crystallization of MPs solubilized in APols would be of high importance for structural biology. However, despite considerable efforts, it is still not clear whether MP/APol complexes can form well-ordered crystals suitable for X-ray crystallography. In the present work, we show that an APol-trapped MP can be crystallized in meso. Bacteriorhodopsin (BR) trapped by APol A8-35 was mixed with a lipidic mesophase, and crystallization was induced by adding a precipitant. The crystals diffract beyond 2 Å. The structure of BR was solved to 2 Å and found to be indistinguishable from previous structures obtained after transfer from detergent solutions. We suggest the proposed protocol of in meso crystallization to be generally applicable to APol-trapped MPs.
536 _ _ |a 452 - Structural Biology (POF2-452)
|0 G:(DE-HGF)POF2-452
|c POF2-452
|f POF II
|x 0
588 _ _ |a Dataset connected to CrossRef, juser.fz-juelich.de, PubMed,
700 1 _ |a Gushchin, I.
|0 P:(DE-Juel1)165798
|b 1
|u fzj
700 1 _ |a Sintsov, M.
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Round, E.
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Balandin, T.
|0 P:(DE-Juel1)131949
|b 4
|u fzj
700 1 _ |a Chervakov, P.
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Shevchenko, Vitaly
|0 P:(DE-Juel1)143908
|b 6
|u fzj
700 1 _ |a Utrobin, P.
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Popov, A.
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Borshchevskiy, V.
|0 P:(DE-Juel1)144613
|b 9
700 1 _ |a Mishin, A.
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Kuklin, A.
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Willbold, D.
|0 P:(DE-Juel1)132029
|b 12
|u fzj
700 1 _ |a Chupin, V.
|0 P:(DE-HGF)0
|b 13
700 1 _ |a Popot, J-L
|0 P:(DE-HGF)0
|b 14
700 1 _ |a Gordeliy, V.
|0 P:(DE-Juel1)131964
|b 15
|e Corresponding Author
|u fzj
773 _ _ |a 10.1007/s00232-014-9700-x
|g Vol. 247, no. 9-10, p. 997 - 1004
|0 PERI:(DE-600)1459323-3
|n 9-10
|p 997 - 1004
|t The @journal of membrane biology
|v 247
|y 2014
|x 1432-1424
856 4 _ |u http://www.ncbi.nlm.nih.gov/pubmed/25192977
856 4 _ |u https://juser.fz-juelich.de/record/185976/files/FZJ-2015-00085.pdf
|y Restricted
909 C O |o oai:juser.fz-juelich.de:185976
|p VDB
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)165798
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)131949
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 6
|6 P:(DE-Juel1)143908
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 12
|6 P:(DE-Juel1)132029
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 15
|6 P:(DE-Juel1)131964
913 2 _ |a DE-HGF
|b Key Technologies
|l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences
|1 G:(DE-HGF)POF3-550
|0 G:(DE-HGF)POF3-551
|2 G:(DE-HGF)POF3-500
|v Functional Macromolecules and Complexes
|x 0
913 1 _ |a DE-HGF
|b Schlüsseltechnologien
|1 G:(DE-HGF)POF2-450
|0 G:(DE-HGF)POF2-452
|2 G:(DE-HGF)POF2-400
|v Structural Biology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF2
|l BioSoft
914 1 _ |y 2014
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)ICS-6-20110106
|k ICS-6
|l Strukturbiochemie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)IBI-7-20200312


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21